Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2025 年第 2 季持倉
持倉截至 2025/6/30，2025/8/14 申報。只含多頭部位，變化是跟 2025 年第 1 季比股數。
- 持股檔數
- 65
- 較 2025 年第 1 季 −4
- 總值
- $31.1 億
- 較 2025 年第 1 季 +$2,232 萬 (+0.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GHGuardant Health, Inc. | COM | 4,250,000 | $2.21 億 | 7.1% | −1,193,721−21.9% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 4,891,544 | $1.93 億 | 6.2% | +327,337+7.2% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 3,245,899 | $1.79 億 | 5.8% | +245,899+8.2% | 加碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 17,791,486 | $1.76 億 | 5.7% | 00.0% | 不變 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 1,750,000 | $1.76 億 | 5.7% | +1,495,249+586.9% | 加碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 3,042,598 | $1.62 億 | 5.2% | −167,672−5.2% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 9,500,000 | $1.52 億 | 4.9% | 00.0% | 不變 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 14,294,420 | $1.33 億 | 4.3% | 00.0% | 不變 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 7,000,000 | $1.21 億 | 3.9% | +2,000,000+40.0% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 3,650,000 | $1.21 億 | 3.9% | +576,147+18.7% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 5,133,917 | $1.06 億 | 3.4% | +1,033,917+25.2% | 加碼 | 歷史 |
| ETNB89bio, Inc. | COM | 9,500,000 | $9,329 萬 | 3.0% | +183,667+2.0% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 801,371 | $8,366 萬 | 2.7% | +801,371 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 5,380,449 | $7,522 萬 | 2.4% | 00.0% | 不變 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,750,000 | $7,089 萬 | 2.3% | +265,734+17.9% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 2,150,000 | $6,990 萬 | 2.2% | +1,400,000+186.7% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 6,064,910 | $6,908 萬 | 2.2% | +564,910+10.3% | 加碼 | 歷史 |
| GERNGeron Corp | COM | 43,000,000 | $6,063 萬 | 1.9% | +4,823,749+12.6% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 1,800,000 | $5,648 萬 | 1.8% | +388,598+27.5% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 1,350,000 | $4,909 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 3,948,910 | $4,845 萬 | 1.6% | +679,784+20.8% | 加碼 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 700,000 | $4,568 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,350,000 | $4,226 萬 | 1.4% | +350,000+35.0% | 加碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 2,233,148 | $4,160 萬 | 1.3% | −124,554−5.3% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 2,000,000 | $4,070 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 900,000 | $3,886 萬 | 1.2% | −1,900,000−67.9% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 16,852,147 | $3,842 萬 | 1.2% | −997,335−5.6% | 減碼 | 歷史 |
| MTSRMetsera, Inc. | COM | 1,094,408 | $3,114 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 7,495,000 | $2,796 萬 | 0.9% | +1,918,442+34.4% | 加碼 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 1,401,938 | $2,786 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 3,480,144 | $2,662 萬 | 0.9% | −99,065−2.8% | 減碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 2,509,301 | $2,507 萬 | 0.8% | +2,509,301 | 新進 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 2,188,592 | $2,497 萬 | 0.8% | −830,343−27.5% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 8,831,007 | $2,473 萬 | 0.8% | −28,641−0.3% | 減碼 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 2,000,000 | $2,438 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 2,426,657 | $2,254 萬 | 0.7% | +426,657+21.3% | 加碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 1,918,798 | $2,151 萬 | 0.7% | +474,089+32.8% | 加碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 4,557,575 | $1,659 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 2,500,000 | $1,623 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| UPBUpstream Bio, Inc. | COM | 1,442,767 | $1,584 萬 | 0.5% | −856,800−37.3% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,442,833 | $1,467 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 275,000 | $1,447 萬 | 0.5% | +275,000 | 新進 | 歷史 |
| HELPCybin Inc. | COM NEW | 1,529,987 | $1,284 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM NEW | 250,000 | $1,218 萬 | 0.4% | +250,000 | 新進 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,203,244 | $836.3 萬 | 0.3% | +436,228+56.9% | 加碼 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 453,686 | $732.2 萬 | 0.2% | +453,686 | 新進 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 500,000 | $657.0 萬 | 0.2% | +500,000 | 新進 | 歷史 |
| NVAXNovavax Inc | COM NEW | 998,542 | $629.1 萬 | 0.2% | −519,640−34.2% | 減碼 | 歷史 |
| IVVDInvivyd, Inc. | COM | 8,585,980 | $613.9 萬 | 0.2% | −1,136,274−11.7% | 減碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 751,422 | $601.1 萬 | 0.2% | +751,422 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $486.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 3,947,807 | $457.9 萬 | 0.1% | −1,451,874−26.9% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 259,800 | $444.3 萬 | 0.1% | −639,931−71.1% | 減碼 | 歷史 |
| XNCRXencor Inc | COM | 549,439 | $431.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 1,981,370 | $403.2 萬 | 0.1% | −1,137,792−36.5% | 減碼 | 歷史 |
| KRROKorro Bio, Inc. | COM | 277,966 | $347.2 萬 | 0.1% | −596,648−68.2% | 減碼 | 歷史 |
| IMAImageneBio, Inc. | COM | 2,515,513 | $337.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 219,015 | $327.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM NEW | 444,110 | $320.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 567,103 | $283.0 萬 | 0.1% | −292,773−34.0% | 減碼 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 1,727,562 | $181.4 萬 | 0.1% | −1,556,221−47.4% | 減碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,040,115 | $129.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SEPNSepterna, Inc. | COM | 121,716 | $128.7 萬 | <0.1% | −1,791,213−93.6% | 減碼 | 歷史 |
| RAPPRapport Therapeutics, Inc. | COM | 98,237 | $111.7 萬 | <0.1% | −359,319−78.5% | 減碼 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 180,510 | $43.1 萬 | <0.1% | −343,479−65.6% | 減碼 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SRPTSarepta Therapeutics, Inc. | COM | $769.5 萬 | – |
2025 年第 1 季之後清倉（11 檔）
2025 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 1 季股數 | 2025 年第 1 季市值 | 2025 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,000,000 | $2.64 億 | 8.5% | 歷史 |
| AMGNAmgen Inc | Stock | 113,035 | $3,522 萬 | 1.1% | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,400,000 | $3,080 萬 | 1.0% | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,000,000 | $2,092 萬 | 0.7% | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 741,068 | $1,862 萬 | 0.6% | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 2,038,845 | $1,621 萬 | 0.5% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 6,011,380 | $733.4 萬 | 0.2% | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 315,765 | $616.7 萬 | 0.2% | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM | 3,262,564 | $570.9 萬 | 0.2% | 歷史 |
| ALLKAllakos Inc. | COM | 7,232,701 | $164.6 萬 | 0.1% | 歷史 |
| NGNENeurogene Inc. | COM | 116,660 | $136.6 萬 | <0.1% | 歷史 |